Clinical Research Directory
Browse clinical research sites, groups, and studies.
Design of Personalised SupplemenTs Based on the Gut MicRobiota Through Artificial Intelligence for Alzheimer's Patients
Sponsor: Universidad Complutense de Madrid
Summary
Studies indicate that the intestinal microbiota could have an implication in Alzheimer's disease; recently, a positive relationship has been established between levels of bacterial lipopolysaccharide (LPS) and cerebral amyloidosis and a negative relationship between the production of the chain fatty acid cuts butyrate by the intestinal microbiota and cerebral amyloidosis. Currently there is no effective treatment for Alzheimer's, but studies indicate that a healthy diet such as the Mediterranean diet and physical exercise delay the symptoms of this disease. For all these reasons, it is postulated that introducing changes in the intestinal microbiota through diet may be a new treatment or serve as an adjuvant treatment for Alzheimer's disease.
Official title: Design of Personalised SupplemenTs Based on the Gut MicRobiota of Alzheimer Patients Through Network and Artificial Intelligence Analysis
Key Details
Gender
All
Age Range
60 Years - 85 Years
Study Type
INTERVENTIONAL
Enrollment
120
Start Date
2024-02-01
Completion Date
2025-12-31
Last Updated
2024-12-09
Healthy Volunteers
Yes
Conditions
Interventions
Personalized diet
Personalized supplement designed by artificial intelligence based on the intestinal microbiota and incorporated into diets
Dietary counseling
Dietary advice will be provided to adapt the diet to the nutritional objectives and recommended intakes.
Locations (2)
Hospital Universitario Puerta de Hierro
Majadahonda, Madrid, Spain
Hospital Clínico Universitario Virgen de la Arrixaca
Murcia, Murcia, Spain